A shortage of chemicals that are used to detect prostate and bone tumors is putting patients at risk. This is due to the slowdown in imports, a lack of funding
A shortage of chemicals that are used to detect prostate and bone tumors is putting patients at risk. This is due to the slowdown in imports, a lack of funding
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy,






